Journal of Nanomedicine & Nanotechnology

Huan Xie

Huan Xie
Associate Professor Department of Pharmaceutical Sciences College of Pharmacy and Health Sciences  
USA

Biography

Huan Xie, PhD is an Associate Professor at Department of Pharmaceutical Sciences, College of Pharmacy and Health Sciences. She has a broad background in nano- formulation and targeted drug delivery, with specific focus and expertise in cancer therapy applications. Dr. Xie had over 3-year industrial working experience at Nanospectra Biosciences, Inc., contributing the development of silica/gold nanoshells for photothermal ablation cancer therapy. Now this product is in several clinical trials, becoming one of the very few metal nanoparticle-based systems ever approved by FDA. Dr. Xie joined TSU in 2008 and further applied her expertise in nanodrug formulation and delivery area. She has obtained several prestigious funding awards ever since then, including the prestigious PhRMA grant at 2010, which only awards to two pharmaceutical recipients each year nation-wide; a NIH-RTRN grant at 2011; and NIH-SC3 grant at 2012, which is a four-year close to half million grant. She published over 20 papers and book chapters and is inventor of 1 pending patent. She has delivered over 50 presentations at various international conferences and academic institutions. She received “Minority-serving Institution Faculty Scholar in Cancer Research Award” from American Association for Cancer Research in 2012. Dr. Xie currently is the Director of TSU RCMI Pharmacology core. She served on TSU University Research Advisory Council, University Rank, Tenure, Promotion and Salary Committee, as well as TSU IACUC committee. In addition, she served on editorial board of several journals and is an active reviewer for numerous journals.

Research Interest

I have a broad background in drug formulation, drug delivery, pharmacokinetics and nanotechnology, with specific training, expertise, leadership and motivation to serve as Director of the RCMI Pharmacology Core. After I received my Ph.D. at North Carolina State University with focus on nano-conjugation and intracellular targeting, I became a Senior Research Scientist at Nanospectra Biosciences, Inc., where I worked on silica/gold nanoshells for photothermal ablation cancer therapy for 4 years. And now this product is in several cancer clinical trials. Since I joined Texas Southern University in 2008, I further applied my expertise to my research. In addition to my normal teaching load, I have successfully carried out over 10 research projects, taught over 700 Pharm.D. students and personally mentored over 20 Ph.D., Pharm.D., and undergraduate students as well as collaborated with various researchers from universities and companies across the nation. As PI or co-Investigator on several NIH- and private agent- funded grants, I laid the groundwork for the proposed research by developing novel analytical methods, advanced drug formulations and drug delivery systems, and establishing their pharmacokinetic and biodistribution profiles, as documented in the following publications. In addition, I successfully administered the projects (e.g. staffing, research protections, budget), collaborated with other researchers, and produced several peer-reviewed publications from each project. As a result of these previous experiences, I am aware of the importance of frequent communication among project members and of constructing a realistic research plan, timeline, and budget. The current application builds logically on my prior work.